Searching News Database: Breckenridge Pharmaceutical
HSMN NewsFeed - 1 Oct 2021
Breckenridge Announces Launch of its 10mg strength for Everolimus Tablets (generic for Afinitor(R))
Breckenridge Announces Launch of its 10mg strength for Everolimus Tablets (generic for Afinitor(R))
HSMN NewsFeed - 5 Aug 2021
Breckenridge Announces Final Approval of its ANDA for Apixaban Tablets (generic for Eliquis(R))
Breckenridge Announces Final Approval of its ANDA for Apixaban Tablets (generic for Eliquis(R))
HSMN NewsFeed - 27 Feb 2019
Breckenridge Announces Final Approval of its ANDA for Exemestane Tablets (Aromasin(R))
Breckenridge Announces Final Approval of its ANDA for Exemestane Tablets (Aromasin(R))
HSMN NewsFeed - 27 Mar 2018
Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Entecavir tablets (Baraclude(R))
Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Entecavir tablets (Baraclude(R))
HSMN NewsFeed - 29 Jun 2007
Breckenridge Pharmaceutical, Inc. and Chemo/Liconsa (Spain) Agree to Develop and Market Generic ANDA
Breckenridge Pharmaceutical, Inc. and Chemo/Liconsa (Spain) Agree to Develop and Market Generic ANDA
Additional items found! 3
Members Archive contains
3 additional stories matching:
Breckenridge Pharmaceutical
(Password required)
Breckenridge Pharmaceutical
(Password required)